Defence Therapeutics Inc. (FRA:DTC)
Germany · Delayed Price · Currency is EUR 0.5140
+0.0380 (7.98%)
At close: Dec 19, 2025
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of €24.86 million as of December 22, 2025. Its market cap has increased by 51.51% in one year.
Market Cap
24.86M
Enterprise Value
25.26M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.51
Market Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 60.36M to 24.86M, a decrease of -58.82%. That is a compound annual growth rate of -17.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 24.86M | 17.62% |
| Dec 31, 2024 | 21.13M | -70.23% |
| Dec 29, 2023 | 70.98M | 4.33% |
| Dec 30, 2022 | 68.04M | -49.69% |
| Dec 31, 2021 | 135.24M | 124.04% |
| May 7, 2021 | 60.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 130.23B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |